Skip to main content
. 2023 Dec 8;15(24):5758. doi: 10.3390/cancers15245758

Figure 1.

Figure 1

Study design, with the division of groups according to the treatment duration of the first drug in the sequential treatment. Abbreviations: T, trifluridine/tipiracil; R, regorafenib.